anmeldenNovo Nordisk Aktie
39,14
EUR
-0,23
EUR
-0,57
%
39,15
EUR
-0,38
EUR
-0,95
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 174,75 Mrd. EUR
KGV 14,11 Div. Rendite 3,60%WKN A3EU6F
ISIN DK0062498333
Symbol NONOF
AI Analyse
Werbung
Novo Nordisk Aktie Analyse
| 17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 07.05.19 | Novo Nordisk Reduce | HSBC | |
| 06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 05.03.19 | Novo Nordisk Reduce | HSBC | |
| 11.02.19 | Novo Nordisk Reduce | HSBC | |
| 05.02.19 | Novo Nordisk verkaufen | Barclays Capital | |
| 26.11.18 | Novo Nordisk Reduce | HSBC | |
| 06.11.18 | Novo Nordisk Reduce | HSBC | |
|
Werbung
|
|||
| 21.09.18 | Novo Nordisk Reduce | HSBC | |
| 19.09.18 | Novo Nordisk Reduce | HSBC | |
| 13.08.18 | Novo Nordisk Underweight | Barclays Capital | |
| 22.06.18 | Novo Nordisk Underweight | Barclays Capital | |
| 22.06.18 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 31.05.18 | Novo Nordisk Reduce | HSBC | |
| 03.05.18 | Novo Nordisk Verkaufen | DZ BANK | |
| 08.03.18 | Novo Nordisk Underweight | Barclays Capital | |
| 15.12.17 | Novo Nordisk Verkaufen | DZ BANK | |
| 07.12.17 | Novo Nordisk Reduce | HSBC | |
| 06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 22.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 15.11.17 | Novo Nordisk Underweight | Barclays Capital | |
| 02.11.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 02.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 27.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 19.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 17.10.17 | Novo Nordisk Reduce | HSBC | |
| 13.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 10.10.17 | Novo Nordisk Reduce | HSBC | |
| 13.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 07.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 17.08.17 | Novo Nordisk Reduce | HSBC | |
| 10.08.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 10.08.17 | Novo Nordisk Underweight | Barclays Capital | |
| 10.08.17 | Novo Nordisk Reduce | HSBC | |
| 04.08.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 21.07.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 30.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 27.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 21.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 19.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 04.05.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 04.05.17 | Novo Nordisk Reduce | HSBC | |
| 05.04.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 03.04.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 23.03.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 08.03.17 | Novo Nordisk Underweight | Barclays Capital | |
| 06.02.17 | Novo Nordisk verkaufen | JP Morgan Chase & Co. | |
| 03.02.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 27.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 23.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
Werbung
Werbung
